In Vitro Diagnostics Market in China

1
China IVD Market Forecast
Category Diagnostics Market Report
2
China IVD Market Forecast Analyst View China
In-Vitro Diagnostics Market to exceed US 12
Billion by 2024. Get Free Customization in this
Report Press Release Title China In-Vitro
Diagnostics Market to exceed US 12 Billion by
2024. For more Info https//www.renub.com/china-
in-vitro-diagnostics-market-is-expected-to-grow-wi
th-19-cagr-by-2022-32-nd.php  

3
China In-Vitro Diagnostics Market to exceed US
12 Billion by 2024.
Research Report Title China InVitro
Diagnostics (IVD) Market, By Diagnostics
(Immunoassay, Microbiology, Molecular, SMBG, POCT
etc.) Companies Access Full
Research https//www.renub.com/china-in-vitro-dia
gnostics-ivd-market-forecast-companies-analysis-re
gistration-rules-1089-p.php The report China IVD
Market, by Diagnostics Clinical Chemistry,
Immunoassay, Hematology, Coagulation,
Microbiology, Molecular Testing, Self Monitoring
of Blood Glucose (SMBG), Point of Care Testing
(POCT), Companies (Roche Diagnostics, Sysmex
Corporation, Mindray Medical International
Limited, Shanghai Kehua Bio-Engineering Co. Ltd.,
Abbott Laboratories Others) provides a
complete analysis of China InVitro Diagnostics
(IVD) Market. The market for China In-Vitro
Diagnostics (IVD) is likely to exceed US 12
Billion by the end of year 2024.

4
China In-Vitro Diagnostics Market to exceed US
12 Billion by 2024.
Request a free sample copy of the
report  https//www.renub.com/contactus.php   In
Vitro Diagnostics (IVDs) - Devices and
Reagents In Vitro Diagnostics (IVDs) are medical
devices and accessories that are used to perform
tests on the specimens taken from the human body
such as blood, urine and tissue in order to
treat, mitigate, monitor drug therapies, cure, or
prevent illness or its abnormality. In vitro
diagnostic (IVD) products are those reagents,
instruments, and systems intended for use in the
collection, preparation, and examination of
specimens to diagnose disease or other
conditions, including a decision of the state of
health. A Look on China In Vitro Diagnostic
(IVD) Market By Testing, the Immunoassay
accounted for the largest share of the market in
2016 while Microbiology Market has grown
approximately 4 times in 2016 compared to its
market value in 2007 driven by growing prevalence
of chronic lifestyle diseases, increasing aging
population and demand for tests in urban and
rural areas.

5
China In-Vitro Diagnostics Market to exceed US
12 Billion by 2024.

6
China In-Vitro Diagnostics Market to exceed US
12 Billion by 2024.
In Vitro Diagnostic (IVD) Enhancing Healthcare
System In vitro diagnostic (IVD) is an important
segment of the healthcare industry. The market is
observing rapid growth ignited by technological
enhancements, better diagnostic devices and
tools, advanced monitoring systems, and increased
availability of over-the-counter tests. IVDs add
momentous value to healing processes and medical
diagnoses, strengthening the well-being of the
general public. Client can Purchase this Report
in Sections from below link Access full
Research http//www.renub.com/china-in-vitro-diag
nostics-ivd-market-forecast-companies-analysis-reg
istration-rules-1089-p.php FDA Approval and
Process FDA classifies IVD products into Class I,
II, or III according to the level of regulatory
regulations, with the aim to assure safety and
effectiveness. The classification of an IVD (or
other medical devices) determines the suitable
premarket approval and process.     Class I   
 Class II     Class III

7
China In-Vitro Diagnostics Market to exceed US
12 Billion by 2024.
The Report Studies the China (PRC) IVD Market on
the basis of  Segment Analysis (2007
2024) 1.    Clinical Chemistry Market 2.
   Immunoassay Market 3.    Hematology
Market 4.    Coagulation Market 5.  
 Microbiology Market6.    Molecular Testing
Market7.    Self Monitoring of Blood Glucose
(SMBG) Market 8.    Point of Care Testing (POCT)
Market Key Players (2011 2024) 1.    Roche
Diagnostics 2.    Sysmex Corporation3.  
 Mindray Medical International Limited4.  
 Shanghai Kehua Bio-Engineering Co. Ltd.5.  
 Abbott Laboratories6.    Others

8
Table of Contents for China IVD Market
Key Topics Covered 1. Executive
Summary   2.    China IVD Market (2007
2024)   3.    Market Share China In Vitro
Diagnostics (IVD) (2011 2024) 3.1    Segments
China IVD 3.2    Companies China IVD   4.  
 Segments China IVD Market (2007 2024) 4.1  
 Clinical Chemistry Market 4.2    Immunoassay
Market4.3    Hematology Market 4.4  
 Coagulation Market4.5    Microbiology
Market 4.6    Molecular Diagnostic Market4.7  
 Self Monitoring of Blood Glucose (SMBG)
Market4.8    Point of Care Testing (POCT)
Market   5.    Development Environment of Chinese
IVD Industry 5.1    Healthcare Reforms 5.2  
 Improving Quality at Grass-Root Level5.3  
 Embracing Technology

9
Table of Contents for China IVD Market
6.    China Health Insurance and Reimbursement
Policies 6.1    Health Insurance System 6.2  
 Reimbursement Rules   7.    Registration of In
Vitro Diagnostic Reagents in China 7.1  
 Registration and Filing7.2    Filing Obligation
for Clinical Trials7.3    Clinical Trial
Institutions7.4    Elimination of IVD Loophole
for Research7.5    Change of Manufacturing
Address7.6    Change of Main Supplier of an
Antigen or Antibody7.7    Update on China
In-Vitro Diagnostics Registration   8.    Medical
Devices and Reagents Class Registration in
China 8.1    Process of Medical Device
Registration in China8.2    Classification of
In-vitro Diagnostic Reagents in China 8.3  
 China In-Vitro Diagnostics Reagents

10
Table of Contents for China IVD Market
9.    China IVD Industry Drivers 9.1  
 Increasing Demand from Middle Class for High
Quality Healthcare Products9.2    Rising
Incidences of Lifestyle Diseases in China9.3  
 Growth in Private Hospitals Independent
Diagnostic Centers   10.    China IVD Industry
Challenges 10.1    Chinese Local Firms Lack of
Expertise in Advanced Technology10.2    Cost
Factor Restricts the Contribution of Global IVD
Companies in the Chinese IVD Market10.3  
 Reimbursement Rates varies from Province to
Province in China   11.    Company Sales Analysis
(2011 2024) 11.1    Roche Diagnostics - China
IVD Sales Forecast11.2    Sysmex Corporation -
China IVD Sales Forecast11.3  
 Mindray Medical International Limited - China
IVD Sales Forecast11.4    Shanghai Kehua
Bio-Engineering Co. Ltd. - China IVD Sales
Forecast11.5    Abbott Laboratories - China IVD
Sales Forecast11.6    Others - China IVD Sales
Forecast  

11
Table of Contents for China IVD Market
12.    Profiles of Select Private Clinical Labs
and Diagnostic Services Companies 12.1  
 Zhejiang Dian Diagnostics Technology Co.,
Ltd. 12.2    ADICON Clinical Laboratories
(Privately held) 12.3    Guangzhou Kingmed
Diagnostics Center Co. Ltd. 12.4    Kindstar
Global (Privately held) 12.5    BGI-Shenzhen 12.6 
   OriGene Technologies

12
Get Free Customization in this Report
Diagnostics Market Reports https//www.renub.
com/diagnostics-14-c.php
Renub Research - North America Rajat Gupta 225 Kristie Ln, Roswell Georgia 30076, United States Tel [phone] Email info_at_renub.com www.renub.com Renub Research - Asia Ankit Mishra C 86, Sector 10 Noida 201301, India Tel [phone] Email info_at_renub.com www.renub.com